Finzati - Logo
BBLG logo

Bone Biologics Corporation

BBLG • Biotechnology
$0.57
▲ +0.01 (+1.86%)
Current price
EarningsLatest report: Jun 30, 2026
HIGHER-RISK PROFILECautionConfidence: 70%

Quantitative profile — not an investment recommendation.

Quantitative profile — not an investment recommendation.Methodology
Analysis thesis: Caution is warranted. Recent ratios show weaknesses that may limit returns unless fundamentals improve.
Market Cap
$1.02M
Growth
—
Cash Flow
0/5
Trend
Negative
Evidence
Manageable debt level · 0Healthy liquidity · 13.85Weak profitability
Financial data as of: Jun 30, 2026, 12:00 AM UTCLast earnings update: Jun 30, 2026, 12:00 AM UTCLast profile update: Aug 16, 2026, 12:24 PM UTC

Company Snapshot

Key valuation, quality, financial strength, momentum and analyst data.

Price$0.57
Change1.86%
Shares Out1.80M
Market Cap$1.02M
Enterprise Value$-3.01M
52W Range0.62 - 4.13
Beta0.53
P/E-0.35
P/B0.26
P/FCF-0.39
EV/EBITDA1.02
EV/FCF1.15

Investment DNA

How strong this company looks for long-term investors

47
out of 100
Business Quality
Margins, moat, returns
22/100
Financial Strength
Debt, cash, stability
70/100
Growth Potential
Revenue and expansion
50/100
Price Attractiveness
Cheap or expensive today
95/100
Why this score▼
Manageable debt level · 0Healthy liquidity · 13.85Weak profitability
Analyst view
No analyst data available now.

Company Overview

IPO: 10/13/2021
Industry: Biotechnology
P/B i: 0.26
Debt / Equity i: 0.00
Operating Margin: 0.00%
Net Margin: 0.00%
ROE i: -
ROIC: -

Financial Health

Score14 / 20
Debt / Equity: 0.00
Current Ratio: 13.85
Quick Ratio: 13.85
Status: Good

Insider Transactions

Recent executive and insider activity

Frelick Jeff
Transaction: 01/08/2026
BUY
Change
+16,668
Price
$1.55
Filing
01/21/2026
Type
BUY
Walsh Deina H
Transaction: 01/08/2026
BUY
Change
+8,335
Price
$1.55
Filing
01/21/2026
Type
BUY
Gagnon Robert E.
Transaction: 06/04/2025
BUY
Change
+62,894
Price
$0.88
Filing
06/06/2025
Type
BUY